Skip to content
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Biophytis Biopharmaceutical
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Pre-financed vouchers (PFW)
    • Obligations Hexagon
    • Contact for Investors
  • Contact

    JULY 19, 2021

    Press Releases, StrategyBy admin20 July 2021

    Judgment rendered on July 16, 2021 in the proceedings between Biophytis and Negma Group Ltd by the Execution Judge from the Paris Court of Justice

    X
    Addresses
    Addresses

    BIOPHYTIS France
    Silver Innov’
    54 rue Molière
    94200 Ivry-Sur-Seine
    FRANCE

    Addresses

    BIOPHYTIS USA
    c/o NGIN
    210 Broadway, Suite #201
    Cambridge, MA 02139
    USA

    Addresses

    BIOPHYTIS Brazil
    CIETEC
    Av. Prof. Lineu Prestes
    2242 Cidade Universitária USP
    05508-000 São Paulo
    BRASIL

    Contact
    contact@biophytis.com +33 1 76 28 40 83
    Investors

    investors@biophytis.com

    © Biophytis 2026.

    All Rights Reserved.

    Legal information
    Webdesign by Ex Calibra
    Go to Top
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Contact for Investors
    • Contact